Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Rosalía Valero San Cecilio"'
Autor:
Ana I Sánchez Fructuoso, Andrea Bedia Raba, Eduardo Banegas Deras, Luis A Vigara Sánchez, Rosalía Valero San Cecilio, Antonio Franco Esteve, Leonidas Cruzado Vega, Eva Gavela Martínez, María E González Garcia, Pablo Saurdy Coronado, Nancy D Valencia Morales, Sofía Zarraga Larrondo, Natalia Ridao Cano, Auxiliadora Mazuecos Blanca, Domingo Hernández Marrero, Isabel Beneyto Castello, Javier Paul Ramos, Adriana Sierra Ochoa, Carmen Facundo Molas, Francisco González Roncero, Armando Torres Ramírez, Secundino Cigarrán Guldris, Isabel Pérez Flores
Publikováno v:
Clinical Kidney Journal. 16:1022-1034
Background Sodium–glucose cotransporter-2 inhibitors (SGLT2is) have cardioprotective and renoprotective effects. However, experience with SGLT2is in diabetic kidney transplant recipients (DKTRs) is limited. Methods This observational multicentre st
Autor:
Covadonga López del Moral Cuesta, Sandra Guiral Foz, David Gómez Pereda, José Luis Pérez Canga, Marina de Cos Gómez, Jaime Mazón Ruiz, Ana García Santiago, José Iñigo Romón Alonso, Rosalía Valero San Cecilio, Emilio Rodrigo Calabia, David San Segundo Arribas, Marcos López Hoyos, Juan Carlos Ruiz San Millán
Publikováno v:
Biomedicines, Vol 8, Iss 4, p 72 (2020)
Immunosuppression withdrawal after graft failure seems to favor sensitization. A high percentage of calculated panel-reactive antibody (cPRA) and the development of de novo donor specific antibodies (dnDSA) indicate human leukocyte antigen (HLA) sens
Externí odkaz:
https://doaj.org/article/a5829c30c8144acba624f6647f80a409
Autor:
Emilio Rodrigo, Paloma Barreda, Lucía Cañamero, Marta Boya, María del Mar García Saiz, Rosalía Valero San Cecilio, Lara Belmar Vega, María Kislikova, María Angeles de Cos, Juan Carlos Ruiz San Millán
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Tacrolimus is the main immunosuppressive drug in the vast majority of kidney transplants, but it is a drug with a narrow therapeutic margin. Each centre must establish therapeutic ranges to optimize its efficacy and minimize its t
Autor:
Clara García Carro, Andrea Bedia Raba, Eduardo J Banegas Deras, Luis Alberto Vigara, Rosalía Valero San Cecilio, Leónidas Cruzado Vega, Eva Gavela, García M Elena González, Isabel Pérez-Flores, Francisco Sanchez-Bielsa
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS SGLT2 inhibitors (SGLT2i) are the first-line therapy in patients with type 2 diabetes mellitus (DM2) and CKD, together with metformin according to most recent published guidelines. They are related to better renal and cardiovascul
Autor:
Lara Belmar Vega, Mario Perez Arnedo, Maria Teresa Garcia Unzueta, Rosalía Valero San Cecilio, Adalberto Benito Hernandez, Marina Serrano Fernández, Marina De Cos Gomez, Juan Carlos Ruiz San Millán, Alejandro Aguilera Fernandez, Emilio Rodrigo
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Elevation of cardiac troponin has been shown to be a marker of myocardial ischemia and other cardiovascular pathologies frequently present in patients with CKD. Pretransplant cardiac troponin I (cTNI) has demonstrated its predicto
Autor:
Maria Teresa Garcia Unzueta, Jaime Mazon Ruiz, David San Segundo Arribas, Juan Carlos Ruiz San Millán, José Luis Pérez Canga, Covadonga López del Moral Cuesta, Emilio Rodrigo Calabia, Rosalía Valero San Cecilio, Marina De Cos Gomez, Adalberto Benito Hernandez
Publikováno v:
Journal of Clinical Medicine
Volume 9
Issue 12
Web of Science
Journal of Clinical Medicine, Vol 9, Iss 4112, p 4112 (2020)
Volume 9
Issue 12
Web of Science
Journal of Clinical Medicine, Vol 9, Iss 4112, p 4112 (2020)
Kidney transplantation implies a significant improvement in patient survival. Nevertheless, early mortality after transplant remains high. Growth differentiation factor 15 (GDF-15) is a novel biomarker under study as a mortality predictor in multiple
Autor:
Marcos López-Hoyos, José Iñigo Romón Alonso, Marina De Cos Gomez, Rosalía Valero San Cecilio, David Gómez Pereda, David San Segundo Arribas, Emilio Rodrigo, Juan Carlos Ruiz San Millán, Sandra Guiral, Covadonga López del Moral Cuesta
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Retransplantation is an important option to consider in patients who return to dialysis after graft failure since it reduces mortality. HLA allosensitization hinders retransplantation, and immunosuppression withdrawal after graft
Autor:
Jaime Mazon Ruiz, Juan Carlos Ruiz San Millán, Covadonga López del Moral Cuesta, David San Segundo Arribas, Rosalía Valero San Cecilio, Emilio Rodrigo, M Angeles Ramos Barron, Marina De Cos Gomez, Adalberto Benito Hernandez, Gema Fernández Fresnedo
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Kidney transplantation results a significant improvement in patient survival. Nevertheless, mortality the first years after transplant remains relatively high, being mostly related to cardiovascular (CV) events. The selection of p
Autor:
M Angeles Ramos Barron, Alvaro Arnau, Rosalía Valero San Cecilio, Juan Carlos Ruiz San Millán, Marcos López-Hoyos, José Luis Pérez Canga, Adalberto Benito Hernandez, Emilio Rodrigo, Covadonga López del Moral Cuesta
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Despite the improvement in renal transplant results, the rate of graft loss from the first year has improved poorly, antibody-mediated rejection (AbMR) being the first cause of renal graft loss. Renal transplantation is usually mo
Autor:
Ana García Santiago, Sandra Guiral Foz, David San Segundo Arribas, Rosalía Valero San Cecilio, Juan Carlos Ruiz San Millán, Emilio Rodrigo Calabia, Covadonga López del Moral Cuesta, Marina de Cos Gómez, David Gómez Pereda, José Luis Pérez Canga, José Iñigo Romón Alonso, Jaime Mazon Ruiz, Marcos López Hoyos
Publikováno v:
Biomedicines
Volume 8
Issue 4
Biomedicines, Vol 8, Iss 72, p 72 (2020)
Volume 8
Issue 4
Biomedicines, Vol 8, Iss 72, p 72 (2020)
Immunosuppression withdrawal after graft failure seems to favor sensitization. A high percentage of calculated panel-reactive antibody (cPRA) and the development of de novo donor specific antibodies (dnDSA) indicate human leukocyte antigen (HLA) sens